CD19 regulates B cell antigen receptor-mediated MHC class II antigen processing

Vaccine

Volumn 18, Issue 3-4, 1999, Pages 376-386

  Wagle, Neelam M ^a   Kim, Julie H ^a   Pierce, Susan K ^a  

^a MolecBiol& Cell Biol   (United States)

Author keywords

Antigen processing; B cell antigen receptor; B lymphocyte; CD19

Indexed keywords

CD19 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONFERENCE PAPER; CROSS LINKING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PINOCYTOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD19; CELL DIVISION; CROSS-LINKING REAGENTS; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PINOCYTOSIS; RECEPTORS, ANTIGEN, B-CELL; SPLEEN;

EID: 0032876569     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00207-8     Document Type: Conference Paper

References (44)

1. Parker D.C. T cell-dependent B cell activation. Ann. Rev. Immunol. 11:1993;331-360.
2. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:1994;287-299.
3. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Ann. Rev. Immunol. 8:1990;773-793.
4. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Ann. Rev. Immunol. 15:1997;821-850.
5. Pierce S.K., Faassen A.E., Qiu Y., Xu X., Dalke D.P., Schafer P. Regulation of B cell antigen processing. Humphreys R.E., Pierce S.K. Regulation of antigen processing. 1994;144 Academic Press, San Diego.
6. West M.A., Lucocq J.M., Watts C. Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature. 369:1994;147-150.
7. Song W., Cho H., Cheng P., Pierce S.K. Entry of the B-cell antigen receptor and antigen into the class II peptide-loading compartment is independent of receptor cross-linking. J. Immunol. 155:1995;4255-4263.
8. Drake J.R., Webster P., Cambier J.C., Mellman I. Delivery of B cell receptor-internalized antigen to endosomes and class II vesicles. J. Exp. Med. 186:1997;1299-1306.
9. Casten L.A., Lakey E.K., Jelachich M.L., Margoliash E., Pierce S.K. Anti-immunoglobulin augments the B-cell antigen-presentation function independently of internalization of receptor-antigen complex. Proc. Natl. Acad. Sci. USA. 82:1985;5890-5894.
10. Xu X., Press B., Wagle N.M., Cho H., Wandinger-Ness A., Pierce S.K. B cell antigen receptor signaling links biochemical changes in the class II peptide-loading compartment to enhanced processing. Int. Immunol. 8:1996;1867-1876.
11. Wagle N.M., Kim J.H., Pierce S.K. Signaling through the B cell antigen receptor regulates discrete steps in the antigen processing pathway. Cell. Immunol. 184:1998;1.
12. Tedder T.F., Inaoki M., Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 6:1997;107-118.
13. Pezzutto A., Dorken B., Rabinovitch P.S., Ledbetter J.A., Moldenhauer G., Clark E.A. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J. Immunol. 138:1987;2793-2799.
14. Carter R.H., Fearon D.T. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:1992;105-107.
15. Callard R.E., Rigley K.P., Smith S.H., Thurstan S., Shields J.G. CD19 regulation of human B cell responses. J. Immunol. 148:1992;2983-2987.
16. Barrett T.B., Shu G.L., Draves K.E., Pezzutto A., Clark E.A. Signaling through CD19, Fc receptors or transforming growth factor-β: each inhibits the activation of resting human B cells differently. Eur. J. Immunol. 20:1990;1053-1059.
17. Engel P., Zhou L.J., Ord D.C., Sato S., Koller B., Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3:1995;39-50.
18. Rickert R.C., Rajewsky K., Roes J. Impairment of T-cell dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:1995;352-356.
19. Zhou L.J., Smith H.M., Waldschmidt T.J., Schwarting R., Daley J., Tedder T.F. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol. Cell. Biol. 14:1994;3884-3894.
20. Unkeless J.C. Characterization of monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:1979;580-596.
21. Qiu Y., Xu X., Wandinger-Ness A., Dalke D.P., Pierce S.K. Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125:1994;595-605.
22. Faassen A.E., Dalke D., Berton M.T., Warren W.D., Pierce S.K. CD40-CD40-ligand interactions stimulate B cell antigen processing. Eur. J. Immunol. 25:1995;3249-3255.
23. Faassen A.E., Pierce S.K. Cross-linking cell surface class II molecules stimulates Ig-mediated B cell antigen processing. J. Immunol. 155:1995;1737-1745.
24. Reth M., Wienands J. Initiation and processing of signals from the B cell antigen receptor. Ann. Rev. Immunol. 15:1997;453-479.
25. Cambier J.C., Pleiman C.M., Clark M.R. Signal transduction by the B cell antigen receptor and its coreceptors. Ann. Rev. Immunol. 12:1994;457-486.
26. Patel K.J., Neuberger M.S. Antigen presentation by the B cell antigen receptor is driven by the α/β sheath and occurs independently of its cytoplasmic tyrosines. Cell. 74:1993;939-946.
27. Bonnerot C., Lankar D., Hanau D., et al. Role of B cell receptor Igα and Igβ subunits in MHC class II-restricted antigen presentation. Immunity. 3:1995;335-347.
28. Mitchell R.N., Barnes K.A., Grupp S.A., et al. Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes. J. Exp. Med. 181:1995;1705-1714.
29. Knight A.M., Lucocq J.M., Prescott A.R., Ponnambalam S., Watts C. Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Igα/Igβ dimer. EMBO J. 16:1997;3842-3850.
30. Fearon D.T., Carter R.H. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity. Ann. Rev. Immunol. 13:1995;127-149.
31. Dempsey P.W., Allison M.E.D., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:1996;348-350.
32. Brautigan D.L., Ferguson-Miller S., Margoliash E. Mitochondrial cytochrome c: preparation and activity of native and chemically modified cytochrome c. Methods Enzymol. 53:1978;128-164.
33. Casten L.A., Pierce S.K. Receptor-mediated B cell antigen processing: increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures. J. Immunol. 140:1988;404-410.
34. Casten L.A., Kaumaya P., Pierce S.K. Enhanced T cell responses to antigenic peptides targeted to B cell surface Ig, Ia or Class I molecules. J. Exp. Med. 168:1988;171-180.
35. Pennell C.A., Arnold L.W., Lutz P.M., LoCasio N.J., Willoughby P.B., Haughton G. Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B cell lymphomas: etiological implications. Proc. Natl. Acad. Sci. USA. 82:1985;3799-3803.
36. Lakey E.K., Margoliash E., Fitch F.W., Pierce S.K. Role of L3T4 and Ia in the heteroclitic response of T cells to cytochrome c. J. Immunol. 136:1986;3933-3938.
37. Gillis S., Ferm M.M., Ou W., Smith K.A. T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120:1978;2027-2032.
38. Ozato K., Mayer N., Sachs D.H. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia-antigens. J. Immunol. 124:1980;533-540.
39. Davignon D., Martz E., Reynolds T., Kurzinger K., Springer T.A. Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T-lymphocyte mediated killing. Proc. Natl. Acad. Sci. USA. 78:1981;4535-4539.
40. Krop I., deFougerolles A.R., Hardy R.R., Allison M., Schlissel M.S., Fearon D.T. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:1996;238-242.
41. Jelachich M.L., Grusby M.J., Clark D., Tasch D., Margoliash E., Pierce S.K. Synergistic effects of antigen and soluble T-cell factors in B-lymphocyte activation. Proc. Natl. Acad. Sci. USA. 81:1984;5537-5541.
42. Goldstein J.L., Basu S.K., Brown M.S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98:1983;241-260.
43. Schafer P.H., Pierce S.K. Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity. 1:1994;699-707.
44. Wagle N.M., Faassen A.E., Kim J.H., Pierce S.K. Regulation of B cell receptor-mediated class II antigen processing by FcγRIIB1. J Immunol. 162:1999;2732-2734.